Home / Products / Genome-edited Cells / Pkd1 Knockout GC-1spg Cell Line

Pkd1 Knockout GC-1spg Cell Line

Cat. No. ARG0237
Product Type:

Genome-edited Cells

In stock
Request a Quote

Short Description 🔒

The Pkd1 Knockout GC-1spg Cell Line is a CRISPR/Cas9-edited knockout cell line derived from mouse spermatogonial cells (GC-1spg). It eliminates polycystin-1, a mechanosensory receptor that complexes with polycystin-2 to control calcium, cAMP, and mTOR signaling, impacting pathways mediated by G proteins, ERK, and transcription factors such as STAT3 and CREB. This model is valuable for studying polycystic kidney disease, ciliopathies, and male fertility defects. It enables investigations into mechanotransduction, spermatogenesis, and cilia biology, using assays like immunofluorescence for cilia markers, calcium imaging, and mTOR activity measurement.

Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Product Type:
Genome-edited Cells
Disease:
Normal
Age:
10 days
Size/Quantity:
1 million
Shipping info:
Cryopreserved in vials and shipped on dry ice

Cell Engineering Information

Host Cell:
GC-1spg
Gene Name:
Pkd1
Gene Alias:
PC1, polycystin 1, polycystin-1, transient receptor potential channel interacting; PC-1
Gene Identifier:
NCBI Gene ID 18763
Gene Species:
Mus musculus (Mouse)
Gene Type:
protein coding gene
Gene Family:
C-type lectin-like/link domain superfamily

Immortalization Information

No immortalization information available.

Culture Conditions

Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Mycoplasma testing:
Negative for mycoplasma through PCR analysis
Sterility testing:
Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.
Pathogens:
Cells tested negative for HIV-1, HBV, and HCV.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".

Description 🔒

The Pkd1 Knockout GC-1spg Cell Line is a CRISPR/Cas9-edited knockout cell line derived from mouse GC-1spg spermatogonial cells. It features targeted disruption of Pkd1, encoding polycystin-1 (PC1). This loss-of-function model enables dissection of PC1 signaling in male germ cells. Supplied as a stable cell line, it ensures consistent experimental outcomes without recurrent transfection or selection.

GC-1spg cells originate from murine spermatogonial cells of the male germ cell lineage, crucial for spermatogenesis. They retain features of spermatogonial stem/progenitor cells, supporting proliferation and differentiation in vitro. Importantly, these cells express primary cilia, making them apt for investigating cilia-dependent pathways in germ cell development.

Polycystin-1 acts as a mechanosensor and signaling receptor, complexing with polycystin-2 (PKD2) at cilia and the plasma membrane. It is activated by fluid shear stress and extracellular matrix interactions, regulating intracellular calcium via G proteins and TRPC1. Downstream, PC1 orchestrates mTORC1, cAMP/PKA, and ERK cascades, influencing STAT3, CREB, TAZ/YAP, and NFAT. It interacts with E-cadherin, focal adhesion kinase, ??-catenin, and tuberin, governing cell adhesion, polarity, and proliferation. Loss of PC1 is linked to cystogenesis and ciliopathies.

In GC-1spg spermatogonial cells, Pkd1 knockout disrupts pathways critical for germ cell homeostasis. PC1-mediated mechanotransduction and mTOR modulation are essential for spermatogonial stem cell maintenance and differentiation. Loss of PC1 may impair cilia function, calcium signaling, and mTORC1 activity, leading to defective proliferation or apoptosis, and thereby male infertility. This model provides a platform to study how polycystin signaling integrates mechanical and chemical cues in testicular biology.

The knockout cell line is applicable for autosomal dominant polycystic kidney disease modeling, cilia biology, spermatogenesis research, and mechanotransduction studies. It supports drug screening targeting mTOR, cAMP, or calcium pathways, and male fertility investigations. Key assays include Western blotting for PC1, RT-qPCR for downstream targets, immunofluorescence for cilia markers (acetylated tubulin, Arl13b), calcium imaging, mTOR activity assays (phospho-S6), co-immunoprecipitation with PC2, and migration assays. For further information, contact Ascent Research.